Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2025 Sep 17:2025.02.25.640184.
doi: 10.1101/2025.02.25.640184.

Open-Source DNA-Encoded Library informatics Package for Design, Decoding, and Analysis: DELi

Affiliations

Open-Source DNA-Encoded Library informatics Package for Design, Decoding, and Analysis: DELi

James Wellnitz et al. bioRxiv. .

Abstract

DNA-encoded library (DEL) technology has become a powerful tool in modern drug discovery. Fully harnessing its potential requires the use of extensive computational methodologies, which are often available only through proprietary software. This restricts accessibility for small teams lacking robust informatics support, hindering the growth of the technology. Here, we present DELi, an open-source DEL informatics platform designed for library design, NGS decoding and calling, and enrichment analysis. DELi supports a simple and easy to understand configuration setup to present a straightforward user interface. To showcase its capabilities, we used DELi to design an in-house custom, benzimidazole-based DEL (UNC DEL006), and performed proof-of-concept selection experiments against Bromodomain-containing Protein 4 (BRD4). The DELi decoding and analysis modules identified top-performing compounds, leading to the off-DNA synthesis of UNC11951, which was confirmed as a nanomolar BRD4 binder via isothermal titration calorimetry (ITC) and differential scanning fluorimetry (DSF). These results demonstrate DELi as an effective tool for DEL design and analysis. Furthermore, its open-source nature will promote ongoing development and contributions from the DEL community to expand its applications and capabilities, making DEL technology more widely accessible.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Authors declare no competing interests.

Figures

Figure 1:
Figure 1:
Sample graphs generated by the DELi decoding HTML report: A) Pie chart showing how many reads failed to be decoded and the relevant cause. B) Pie chart of which libraries were found in the selection and the percentages of UMI corrected counts attributed to that library (above a cutoff of 1%).
Figure 2.
Figure 2.. Automated DELi Analysis Report Accelerates Selection QC and ML Workflows.
A) Header from DELi report detailing sampling depth and experimental conditions. B) Top AB-disynthon features from UNC DEL006, nominated by their enrichment over an NTC condition. The Venn diagram displays the AB-disynthon feature reproducibility across the three replicate selections, given a user-defined enrichment threshold. C) Automated DEL-ML RF classification model created by DELi’s data balancing functions contrasted with dummy classifier to display overall accuracy from 5-fold training regime.
Figure 3.
Figure 3.. DELi Analysis Module Nominates nM Binder From DEL Selection.
A) Top trisynthon compounds for SAR analysis utilizing a normalized z-score metric. B). ITC data for the top-nominated compound UNC11951, demonstrating nanomolar binding affinity, compared to the structurally similar UNC11954, which was not nominated by DELi’s automated report and showed no measurable binding affinity by ITC. C) Thermal shift assay results: melting curves (top) and calculated Tm values (bottom) for four-point dose-response experiments (20 to 2.5 μM) with UNC11951 and UNC11954. Tm values were determined by fitting the raw fluorescence data using the Boltzmann sigmoidal equation in GraphPad Prism. Error bars indicate the standard deviation of the calculated Tm values (n=3).

References

    1. AI’s Potential to Accelerate Drug Discovery Needs a Reality Check. Nature 2023, 622 (7982), 217–217. 10.1038/d41586-023-03172-6. - DOI - PubMed
    1. Jaroszewicz W.; Morcinek-Orłowska J.; Pierzynowska K.; Gaffke L.; Węgrzyn G. Phage Display and Other Peptide Display Technologies. FEMS Microbiol. Rev. 2022, 46 (2), fuab052. 10.1093/femsre/fuab052. - DOI - PubMed
    1. Sergeeva A.; Kolonin M. G.; Molldrem J. J.; Pasqualini R.; Arap W. Display Technologies: Application for the Discovery of Drug and Gene Delivery Agents. Adv. Drug Deliv. Rev. 2006, 58 (15), 1622–1654. 10.1016/j.addr.2006.09.018. - DOI - PMC - PubMed
    1. Gironda-Martínez A.; Donckele E. J.; Samain F.; Neri D. DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges. ACS Pharmacol. Transl. Sci. 2021, 4 (4), 1265–1279. 10.1021/acsptsci.1c00118. - DOI - PMC - PubMed
    1. Satz A. L.; Brunschweiger A.; Flanagan M. E.; Gloger A.; Hansen N. J. V.; Kuai L.; Kunig V. B. K.; Lu X.; Madsen D.; Marcaurelle L. A.; Mulrooney C.; O’Donovan G.; Sakata S.; Scheuermann J. DNA-Encoded Chemical Libraries. Nat. Rev. Methods Primer 2022, 2 (1), 1–17. 10.1038/s43586-021-00084-5. - DOI

Publication types

LinkOut - more resources